{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:24:13Z","timestamp":1792718653938,"version":"4.5.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute myeloid leukemia (AML) is a heterogeneous group of malignancies that may be sensitive to the NK cell antitumor response. However, NK cells are frequently defective in AML. In this study, we found in an exploratory cohort (n = 46) that NK cell status at diagnosis of AML separated patients in two groups with a different clinical outcome. Patients with a deficient NK cell profile, including reduced expression of some activating NK receptors (e.g., DNAX accessory molecule-1, NKp46, and NKG2D) and decreased IFN-\u03b3 production, had a significantly higher risk of relapse (p = 0.03) independently of cytogenetic classification in multivariate analysis. Patients with defective NK cells showed a profound gene expression decrease in AML blasts for cytokine and chemokine signaling (e.g., IL15, IFNGR1, IFNGR2, and CXCR4), Ag processing (e.g., HLA-DRA, HLA-DRB1, and CD74) and adhesion molecule pathways (e.g., PVR and ICAM1). A set of 388 leukemic classifier genes defined in the exploratory cohort was independently validated in a multicentric cohort of 194 AML patients. In total, these data evidenced the interplay between NK cells and AML blasts at diagnosis allowing an immune-based stratification of AML patients independently of clinical classifications.<\/jats:p>","DOI":"10.4049\/jimmunol.1500262","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T01:57:41Z","timestamp":1438826261000},"page":"2580-2590","source":"Crossref","is-referenced-by-count":89,"title":["Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion"],"prefix":"10.1093","volume":"195","author":[{"given":"Zena","family":"Khaznadar","sequence":"first","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1160 , 75010 Paris ,","place":["France"]},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Service d\u2019H\u00e9matologie Adulte, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , EA3518, 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Agaugu\u00e9","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1160 , 75010 Paris ,","place":["France"]},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guylaine","family":"Henry","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Immunologie et Histocompatibilit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyling","family":"Cheok","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1172 , 59045 Lille ,","place":["France"]},{"name":"Laboratoire d\u2019H\u00e9matologie, Centre de Biologie-Pathologie Centre Hospitalier R\u00e9gional Universitaire Lille, Universit\u00e9 de Lille , 59000 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Vignon","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1160 , 75010 Paris ,","place":["France"]},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Geromin","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Laboratoire d\u2019H\u00e9matologie Biologique, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]},{"name":"Tumoroth\u00e8que, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Cayuela","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Laboratoire d\u2019H\u00e9matologie Biologique, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]},{"name":"Tumoroth\u00e8que, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Castaigne","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Versailles-Saint Quentin , 78000 Versailles ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pautas","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est Cr\u00e9teil , 94000 Cr\u00e9teil ,","place":["France"]},{"name":"Service d\u2019H\u00e9matologie Clinique, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Henri Mondor , 94000 Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Raffoux","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Adulte, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , EA3518, 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Lachuer","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1052, Centre de Recherche en Canc\u00e9rologie de Lyon , 69008 Lyon ,","place":["France"]},{"name":"Centre National pour la Recherche Scientifique, Unit\u00e9 Mixte de Recherche-5286, Centre de Recherche en Canc\u00e9rologie de Lyon , 69008 Lyon ,","place":["France"]},{"name":"Universit\u00e9 Unit\u00e9 Mixte de Recherche-S1052, Centre de Recherche en Canc\u00e9rologie de Lyon , 69008 Lyon ,","place":["France"]},{"name":"Universit\u00e9 de Lyon , 69000 Lyon ,","place":["France"]},{"name":"ProfileXpert , 69008 Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Sigaux","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1172 , 59045 Lille ,","place":["France"]},{"name":"Laboratoire d\u2019H\u00e9matologie, Centre de Biologie-Pathologie Centre Hospitalier R\u00e9gional Universitaire Lille, Universit\u00e9 de Lille , 59000 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Service d\u2019H\u00e9matologie Adulte, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , EA3518, 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dulphy","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1160 , 75010 Paris ,","place":["France"]},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Laboratoire d\u2019Immunologie et Histocompatibilit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Toubert","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche-S1160 , 75010 Paris ,","place":["France"]},{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Laboratoire d\u2019Immunologie et Histocompatibilit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, H\u00f4pital Saint-Louis , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"2025030704130065100_r1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"key":"2025030704130065100_r2","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"2025030704130065100_r3","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"2025030704130065100_r4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"2025030704130065100_r5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.it.2004.04.005","article-title":"NK cells: innate immunity against hematological malignancies?","volume":"25","author":"Costello","year":"2004","journal-title":"Trends Immunol."},{"key":"2025030704130065100_r6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.coi.2008.03.005","article-title":"Line of attack: NK cell specificity and integration of signals","volume":"20","author":"Bryceson","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"2025030704130065100_r7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","article-title":"Location and cellular stages of natural killer cell development","volume":"34","author":"Yu","year":"2013","journal-title":"Trends Immunol."},{"key":"2025030704130065100_r8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.leu.2405040","article-title":"NK cell receptors and their ligands in leukemia","volume":"22","author":"Verheyden","year":"2008","journal-title":"Leukemia"},{"key":"2025030704130065100_r9","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"key":"2025030704130065100_r10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction","volume":"109","author":"Fauriat","year":"2007","journal-title":"Blood"},{"key":"2025030704130065100_r11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J. Exp. Med."},{"key":"2025030704130065100_r12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2004.07.028","article-title":"PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis","volume":"42","author":"Pende","year":"2005","journal-title":"Mol. Immunol."},{"key":"2025030704130065100_r13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/leu.2008.354","article-title":"Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate","volume":"23","author":"Poggi","year":"2009","journal-title":"Leukemia"},{"key":"2025030704130065100_r14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.leukres.2007.02.020","article-title":"Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis","volume":"31","author":"Rohner","year":"2007","journal-title":"Leuk. Res."},{"key":"2025030704130065100_r15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3324\/haematol.2013.087536","article-title":"Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia","volume":"99","author":"Stringaris","year":"2014","journal-title":"Haematologica"},{"key":"2025030704130065100_r16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2025030704130065100_r17","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1182\/blood-2008-02-134411","article-title":"An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia","volume":"112","author":"Metzeler","year":"2008","journal-title":"Blood"},{"key":"2025030704130065100_r18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2025030704130065100_r19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2013-02-485771","article-title":"Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients","volume":"123","author":"Rapin","year":"2014","journal-title":"Blood"},{"key":"2025030704130065100_r20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"2025030704130065100_r21","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"2025030704130065100_r22","volume-title":"ISCN 1995. An International System for Human Cytogenetic Nomenclature. Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature.","author":"Mitelman","year":"1995"},{"key":"2025030704130065100_r23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(12)60485-1","article-title":"Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study","volume":"379","author":"Castaigne","year":"2012","journal-title":"Lancet"},{"key":"2025030704130065100_r24","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4049\/jimmunol.181.3.2227","article-title":"An unusual CD56bright CD16low NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation","volume":"181","author":"Dulphy","year":"2008","journal-title":"J. Immunol."},{"key":"2025030704130065100_r25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/bioinformatics\/18.1.207","article-title":"Genesis: cluster analysis of microarray data","volume":"18","author":"Sturn","year":"2002","journal-title":"Bioinformatics"},{"key":"2025030704130065100_r26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"2025030704130065100_r27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"2025030704130065100_r28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J. R. Stat. Soc., B"},{"key":"2025030704130065100_r29","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."},{"key":"2025030704130065100_r30","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030704130065100_r31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"2025030704130065100_r32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cpr.12057","article-title":"Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients","volume":"46","author":"Reikvam","year":"2013","journal-title":"Cell Prolif."},{"key":"2025030704130065100_r33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/stemcells.2005-0185","article-title":"Global gene expression profile of human cord blood-derived CD133+ cells","volume":"24","author":"Jaatinen","year":"2006","journal-title":"Stem Cells"},{"key":"2025030704130065100_r34","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/sj.leu.2404401","article-title":"Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells","volume":"20","author":"Gal","year":"2006","journal-title":"Leukemia"},{"key":"2025030704130065100_r35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat. Med."},{"key":"2025030704130065100_r36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM199303043280904","article-title":"Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia","volume":"328","author":"L\u00f6wenberg","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"2025030704130065100_r37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood.V82.3.899.899","article-title":"Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia","volume":"82","author":"Hunter","year":"1993","journal-title":"Blood"},{"key":"2025030704130065100_r38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat. Genet."},{"key":"2025030704130065100_r39","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"key":"2025030704130065100_r40","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.leu.2404808","article-title":"Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias","volume":"21","author":"Mullighan","year":"2007","journal-title":"Leukemia"},{"key":"2025030704130065100_r41","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1182\/blood-2005-05-2168","article-title":"Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance","volume":"106","author":"Verhaak","year":"2005","journal-title":"Blood"},{"key":"2025030704130065100_r42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2025030704130065100_r43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"key":"2025030704130065100_r44","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.20110304","article-title":"BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia","volume":"208","author":"Hurtz","year":"2011","journal-title":"J. Exp. Med."},{"key":"2025030704130065100_r45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"key":"2025030704130065100_r46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2008.02.003","article-title":"BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells","volume":"41","author":"Ranuncolo","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"2025030704130065100_r47","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","article-title":"Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia","volume":"99","author":"Costello","year":"2002","journal-title":"Blood"},{"key":"2025030704130065100_r48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/icb.2011.15","article-title":"Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients","volume":"90","author":"Sanchez-Correa","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"2025030704130065100_r49","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/eji.201444500","article-title":"Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse","volume":"44","author":"Khaznadar","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"2025030704130065100_r50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2025030704130065100_r51","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2025030704130065100_r52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3324\/haematol.2011.057901","article-title":"The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia","volume":"97","author":"Tiacci","year":"2012","journal-title":"Haematologica"},{"key":"2025030704130065100_r53","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders","volume":"122","author":"Damm","year":"2013","journal-title":"Blood"},{"key":"2025030704130065100_r54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coi.2014.04.002","article-title":"Shaping of NK cell subsets by aging","volume":"29","author":"Solana","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"2025030704130065100_r55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-009-0724-5","article-title":"Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors","volume":"59","author":"Szczepanski","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030704130065100_r56","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/annonc\/mdv081.2","article-title":"O3.2Phase I and dose ranging, phase II studies with IPH2201, a humanized monoclonal antibody targeting HLA-E receptor CD94\/NKG2A","volume":"26","author":"Seymour","year":"2015","journal-title":"Ann. Oncol."},{"key":"2025030704130065100_r57","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2012-06-437558","article-title":"A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission","volume":"120","author":"Vey","year":"2012","journal-title":"Blood"},{"key":"2025030704130065100_r58","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2007-07-101311","article-title":"NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities","volume":"111","author":"Diermayr","year":"2008","journal-title":"Blood"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/195\/6\/2580\/61504470\/1500262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/195\/6\/2580\/61504470\/1500262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:28:26Z","timestamp":1741321706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/195\/6\/2580\/7961533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,9,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1500262","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9]]},"published":{"date-parts":[[2015,9]]}}}